<h3>Gainers</h3>
<ul>
<li>Cue Biopharma (NASDAQ:CUE) stock rose 90.1% to $28.02 during Friday's pre-market session. The company's market cap stands at $47.9 million. </li>
<li>Esperion Therapeutics (NASDAQ:ESPR) stock increased by 57.0% to $3.14. The company's market cap stands at $514.8 million. </li>
<li>Akanda (NASDAQ:AKAN) shares rose 30.26% to $63.78. The company's market cap stands at $26.1 million. </li>
<li>Psyence Biomedical (NASDAQ:PBM) stock moved upwards by 19.11% to $7.85. The market value of their outstanding shares is at $6.7 million. </li>
<li>iSpecimen (NASDAQ:ISPC) stock increased by 17.2% to $6.13. The company's market cap stands at $3.8 million. </li>
<li>Cerus (NASDAQ:CERS) stock rose 15.02% to $2.33. The market value of their outstanding shares is at $406.7 million. As per the news, the Q1 earnings report came out yesterday. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Akari Therapeutics (NASDAQ:AKTX) shares decreased by 25.9% to $4.0 during Friday's pre-market session. The market value of their outstanding shares is at $192.9 million. </li>
<li>Senseonics Holdings (NASDAQ:SENS) shares fell 22.24% to $5.14. The company's market cap stands at $276.3 million. </li>
<li>Rein Therapeutics (NASDAQ:RNTX) shares fell 21.78% to $1.06. The company's market cap stands at $37.9 million. </li>
<li>Summit Therapeutics (NASDAQ:SMMT) stock decreased by 20.55% to $17.05. The company's market cap stands at $16.6 billion. As per the press release, Q1 earnings came out yesterday. </li>
<li>Sotera Health (NASDAQ:SHC) stock decreased by 10.75% to $13.89. The market value of their outstanding shares is at $4.4 billion. </li>
<li>Crescent Biopharma (NASDAQ:CBIO) stock decreased by 8.68% to $20.43. The company's market cap stands at $681.4 million. As per the press release, Q1 earnings came out 2 days ago. 
See Also: www.benzinga.com/money/best-healthcare-stocks/</li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ESPR

In Friday's pre-market session, Cue Biopharma saw a significant gain of 90.1%, reaching $28.02, while Esperion Therapeutics rose by 57% to $3.14. Other notable gainers included Akanda (+30.26%), Psyence Biomedical (+19.11%), and iSpecimen (+17.2%). Conversely, Akari Therapeutics dropped 25.9% to $4.00, with Senseonics Holdings and Rein Therapeutics also experiencing declines. Summit Therapeutics fell by 20.55% to $17.05, and Sotera Health decreased by 10.75% to $13.89. Q1 earnings reports were released recently for several companies.

benzinga_article

Esperion Therap

Cue BioPharma

Invesco Biotechnology & Genome ETF

First Trust NYSE Arca Biotech Index Fd

ALPS Medical Breakthrough

Direxion S&P Biotech Bull 3X

SPDR S&P Health Equip

iShares US Healthcare Providers

VG Health

iShares US Pharma

iShares Biotechnology ETF

iShares Global Healthcare

Invesco Nasdaq Biotechnology ETF

VanEck Biotech ETF

iShares US Medical Devices

Akanda

Psyence Biomedical

iSpecimen

Cerus

Akari Therap

Senseonics

Rein Therapeutics

Summit Therapeutics

Sotera Health

Crescent Biopharma

PSYENCE BIOMEDICAL LTD C/WTS 25/01/2029(TO PUR COM)

12 Health Care Stocks Moving In Friday's Pre-Market Session